Effect of Rituximab Compared with Natalizumab and Fingolimod in Patients with Relapsing-Remitting Multiple Sclerosis: A Cohort Study.

Autor: Hernández-Preciado MR; High Specialty Medical Unit, Western National Medical Center of the Mexican Institute of Social Security, Guadalajara 44340, Mexico.; Neurosciences Division, Western Biomedical Research Center (IMSS), Guadalajara 44340, Mexico., Marquez-Pedroza J; High Specialty Medical Unit, Western National Medical Center of the Mexican Institute of Social Security, Guadalajara 44340, Mexico., Sánchez-Rosales NA; High Specialty Medical Unit, Western National Medical Center of the Mexican Institute of Social Security, Guadalajara 44340, Mexico., García-Rivera JJ; High Specialty Medical Unit, Western National Medical Center of the Mexican Institute of Social Security, Guadalajara 44340, Mexico., Kobayashi-Gutiérrez A; High Specialty Medical Unit, Western National Medical Center of the Mexican Institute of Social Security, Guadalajara 44340, Mexico., Torres-Mendoza BM; Neurosciences Division, Western Biomedical Research Center (IMSS), Guadalajara 44340, Mexico.; Department of Philosophical and Methodological Disciplines, University Health Sciences Center, University of Guadalajara, Guadalajara 44340, Mexico., Chavarría-Avila E; Department of Philosophical and Methodological Disciplines, University Health Sciences Center, University of Guadalajara, Guadalajara 44340, Mexico., Montaño-Serrano RA; Department of Physiology, University of Guadalajara, Guadalajara 44340, Mexico., Cortes-Enriquez F; Department of Neurology, Hospital General Regional No 45 of the Mexican Institute of Social Security, Guadalajara 44910, Mexico., Mireles-Ramírez MA; High Specialty Medical Unit, Western National Medical Center of the Mexican Institute of Social Security, Guadalajara 44340, Mexico.

Publikováno v: Journal of clinical medicine [J Clin Med] 2022 Jun 22; Vol. 11 (13). Date of Electronic Publication: 2022 Jun 22.